NFE2L2 and cancer: However, aberrant expression of NRF2 as a result of upregulation of miR-153, increases sensibility of cancer cells and CSCs to radio/chemotherapy in some types of cancer cells including esophageal squamous cell carcinoma and glioma stem cells (15, 74).